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Erv14p is a conserved integral membrane protein that traffics in COPII-coated vesicles and
localizes to the early secretory pathway in yeast. Deletion of ERV14 causes a defect in polarized
growth because Axl2p, a transmembrane secretory protein, accumulates in the endoplasmic
reticulum and is not delivered to its site of function on the cell surface. Herein, we show that
Erv14p is required for selection of Axl2p into COPII vesicles and for efficient formation of these
vesicles. Erv14p binds to subunits of the COPII coat and binding depends on conserved residues
in a cytoplasmically exposed loop domain of Erv14p. When mutations are introduced into this
loop, an Erv14p-Axl2p complex accumulates in the endoplasmic reticulum, suggesting that
Erv14p links Axl2p to the COPII coat. Based on these results and further genetic experiments, we
propose Erv14p coordinates COPII vesicle formation with incorporation of specific secretory
cargo.
INTRODUCTION
Intracellular transport pathways between organelles of the
early secretory pathway depend on coat protein complexes
that deform membranes and collect specific cargo molecules.
Activated small GTPases are thought to attract coat proteins
to specific membrane export sites and physically link coats
to export cargo. As coats polymerize, vesicles form and are
budded from membrane-bound organelles (reviewed in
Springer et al., 1999). Although vesicle coats and coat recog-
nition motifs have been identified for some transmembrane
cargo (Cosson and Letourneur, 1994; Nishimura and Balch,
1997), many trafficking proteins do not contain known mo-
tifs and the molecular mechanisms underlying selective ex-
port are not understood.
Transport of newly synthesized secretory proteins from
the endoplasmic reticulum (ER) depends on a coat complex
termed COPII, which consists of the small GTPase Sar1p, the
Sec23/24p complex, and the Sec13/31p complex (Barlowe et
al., 1994). Morphological and biochemical experiments have
demonstrated that certain secretory proteins are concen-
trated into ER-derived vesicles during transport from this
compartment (Quinn et al., 1984; Salama et al., 1993; Balch et
al., 1994; Bednarek et al., 1995). Furthermore, specific COPII–
cargo complexes have been characterized that in many in-
stances depend on the activated form of the Sar1p GTPase
(Aridor et al., 1998; Kuehn et al., 1998; Springer et al., 1999).
These results indicate that specific vesicle cargo is concen-
trated into ER-derived vesicles through direct or indirect
interactions with COPII subunits. Additional evidence sug-
gests that cargo receptors are required in some instances to
link soluble secretory cargo to vesicle coats (Kuehn et al.,
1998; Muniz et al., 2000). However, some soluble cargo does
not appear to be concentrated during export from the ER
and instead is concentrated during transport through other
compartments of the early secretory pathway (Martinez-
Menarguez et al., 1999). Clearly, the mechanisms that govern
export of distinct secretory cargo from the ER remain to be
elucidated. Toward this goal, we have identified a set of
membrane-bound ER vesicle (Erv) proteins that bind to
subunits of the COPII coat and function in protein transport
between the ER and Golgi (Belden and Barlowe, 1996; Pow-
ers and Barlowe, 1998; Otte et al., 2001). In this report, we
focus on Erv14p and dissect its function in COPII-dependent
transport from the ER.
Yeast Erv14p was identified on COPII-coated vesicles and
localizes to ER and Golgi membranes. Deletion of ERV14
produces viable cells that display a defect in bud site selec-
tion because a transmembrane secretory protein, Axl2p, is
not delivered to the cell surface (Powers and Barlowe, 1998).
Axl2p is required for selection of axial growth sites and
normally localizes to nascent bud tips of the mother bud
neck (Halme et al., 1996; Roemer et al., 1996). In erv14
strains, Axl2p accumulates in the ER, whereas other secre-
tory proteins are transported at near wild-type rates. Based
on these findings, we proposed that Erv14p cycled between
the ER and Golgi compartments and served a role in export
of secretory cargo from the ER (Powers and Barlowe, 1998).
Erv14p is highly conserved and in Drosophila melanogaster
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the homologous protein, known as Cornichon, is essential
for polarity establishment during the early stages of oogen-
esis (Roth et al., 1995). Indeed, it has been proposed that
cornichon operates similarly in ER export of a distinct secre-
tory protein, the transforming growth factor -like signaling
molecule Gurken (Queenan et al., 1999). Thus, a mechanistic
understanding of Erv14p function should contribute to a gen-
eral understanding on sorting during export from the ER.
Herein, we demonstrate that Erv14p associates with both
the COPII coat and the transmembrane secretory protein
Axl2p. In addition, our data indicate that Erv14p acts in
selecting Axl2p into COPII vesicles and for efficient forma-
tion of these vesicles. Previous reports have shown that
integral membrane secretory proteins such as the vesicular
stomatitis virus glycoprotein and plasma membrane ATPase
bind to subunits of the COPII coat (Aridor et al., 1998;
Shimoni et al., 2000). However, there are no examples indi-
cating that integral membrane secretory proteins depend on
vesicle adaptors for export from the ER. Therefore, our
findings may have important implications for transport of a
variety of other integral membrane secretory cargo.
MATERIALS AND METHODS
Media and Growth Conditions
All yeast strains used in this study are listed in Table 1. Cultures
were grown at 30°C in either rich medium (1% Bacto-yeast extract,
2% Bacto-peptone, and 2% dextrose) or minimal medium (0.67%
nitrogen base without amino acids and 2% dextrose) containing the
appropriate supplements for plasmid selection (Sherman, 1991).
Manipulations of recombinant DNA were performed in Escherichia
coli strain DH5 (Ausubel et al., 1987). Thermosensitive sec mutants
(Kaiser and Schekman, 1990) were mated to CBY356 or CBY358 and
resulting diploids induced to sporulate. Tetrads were dissected and
allowed to germinate on YPD plates at room temperature. An
increase in thermosensitivity was more finely explored by growing
identically struck YPD plates at 23, 28, 34, and 37°C. Temperature-
sensitive sec mutants that displayed an enhanced thermosensitivity
when combined with erv14 were backcrossed through the erv14
parent strain twice more to confirm that genetic interactions were
specific and not due to variation in strain backgrounds.
Antibodies and Immunoblotting
Antibodies used in these studies against Bos1p (Cao and Barlowe,
2000), Emp47p, Erv25p, Kar2p, Sec12p, Sec61p, anti-hemagglutinin
(HA), and anti-c-myc, have been described (Powers and Barlowe,
1998). Polyclonal antiserum specific for Erv14p was raised against
the peptide LDATEIFRTLGKHKRESFLK, representing residues 92–
111 of Erv14p. This peptide was linked to KLH and the peptide-
carrier conjugate used for rabbit immunization (Quality Controlled
Biochemicals, Hopkinton, MA). Protein samples were resolved ei-
ther by SDS-PAGE or by Tris/tricine polyacrylamide gels (Schagger
and von Jagow, 1987) and electrophoretically transferred to nitro-
cellulose (Powers and Barlowe, 1998). Peroxidase-catalyzed chemi-
luminescence was used to detect filter-bound antibodies (ECL meth-
od; Amersham Biosciences, Piscataway, NJ). Scanning densitometry
of immunoblots was performed using NIH Image. Calcofluor stain-
ing of bud scars (Pringle, 1991) and subcellular fractionation of
membranes on sucrose density gradients were performed as de-
scribed (Powers and Barlowe, 1998).
Table 1. Strains used in this study
Strain Genotype Reference
CBY355 MAT his3200 ura3-52 leu2l lys2202 trpl 63 Powers and Barlowe, 1998
CBY356 MAT his3 200 ura3-52 leu21 lys2202 trp1 63 erv14::HIS3 Powers and Barlowe, 1998
CBY409 CBY356 containing pRS-ERV14HA Powers and Barlowe, 1998
CBY601 MAT his3200 ura3-52 leu21 lys2202 trp163 This study
CBY602 MAT his3200 ura3-52 leu21 lys2202 trp163 erv14::HIS3 This study
CBY603 MAT his3200 ura3-52 leu21 lys2202 trp163 erv14::HIS3 sec13-1 This study
CBY604 MAT his3200 ura3-52 leu21 lys2202 trp163 sec 13-1 This study
CBY615 MAT his3200 ura3-52 lys2202 trp163 sec 23-1 This study
CBY616 MAT his3200 ura3-52 lys2202 trp163 This study
CBY617 MAT his3200 ura3-52 lys2202 trp163 erv14::HIS3 sec23-1 This study
CBY618 MAT his3200 ura3-52 lys2202 trp163 erv14::HIS3 This study
CBY663 MAT his3200 ura3-52 leu21 lys2202 erv14::HIS3 sec16-2 This study
CBY664 MAT his3200 ura3-52 leu21 lys2202 sec16-2 This study
CBY665 MAT his3200 ura3-52 leu21 lys2202 erv14::HIS3 This study
CBY707 CBY356 containing pRS316-ERV14-(V44)-HA This study
CBY731 CBY356 containing pRS316-ERV14-(L92)-HA This study
CBY732 CBY356 containing KS-ERV14-pro--factor-HA This study
CBY800 CBY356 with AXL2::13MYC This study
CBY807 CBY355 with AXL2::13MYC This study
CBY808 CBY356 containing KS-ERV14-(91-95A)-HA This study
CBY809 CBY356 containing KS-ERV14-(97-101A)-HA This study
CBY812 CBY800 containing pRS316 This study
CBY813 CBY800 containing pRS316-ERV14 -HA This study
CBY816 CBY800 containing KS-ERV14-(91-95A)-HA This study
CBY817 CBY800 containing KS-ERV14-(97-101A)-HA This study
CBY866 CBY800 containing pRS315-ERV14 This study
CBY867 CBY800 containing KS-ERV14-(Y80A)-HA This study
CBY868 CBY800 containing KS-ERV14-(D93A)-HA This study
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Plasmid Construction
Construction of Erv14p-fXa Fusion Proteins. A double-stranded
oligonucleotide encoding the factor Xa protease cleavage recogni-
tion site IEGR was created by annealing the complimentary oligo-
nucleotides JP22 (5-ATCGAGGGTAGA-3) and JP23a (5-TCTAC-
CCTCGAT-3). The annealed oligonucleotides were then inserted
independently into each region of ERV14 predicted to encode loop
domains. For the first loop, the oligonucleotide encoding the factor
Xa recognition motif was inserted into a unique HpaI site at nucle-
otide 132 of ERV14 in pRS316-ERV14-HA (Powers and Barlowe,
1998), creating the plasmid pRS316-ERV14-(V44)-HA. For the sec-
ond loop, site-directed mutagenesis was used to create a unique
NruI site at nucleotide 276 in the plasmid pRS316-ERV14-HA. The
CLONTECH Transformer Mutagenesis kit (Palo Alto, CA) was used
for this construct and others that required site-directed mutagene-
sis. Oligonucleotide primers JP28 (5-GGGGGGGCCC AGTACT-
CAGC TTTTGTTCC-3) and JP30 (5-GAATATTTCG GTAGCT-
CGCG AAAGTTGAAC TTTATTGTAG-3) were used for the
selection mutation (changing the unique KpnI site in pRS316 to a
ScaI site) and for the site-directed mutation, respectively. The oli-
gonucleotide encoding the factor Xa recognition motif was then
cloned into the new NruI site, creating the construct pRS316-ERV14-
(L92)-HA. In both insertion constructs, proper integration and ori-
entation of a single factor Xa protease cleavage site was confirmed
by sequence analysis.
Construction of Erv14p-pro-factor-HA Fusion Protein. Pro-fac-
tor was fused to the C terminus of Erv14p by using the MF1 gene
contained on plasmid pDJ100 (Hansen et al., 1986) as template in a
polymerase chain reaction (PCR) with primers JP20 (5-CGGGG-
TACCG CTCCAGTCAA CACTACAACA GAAG-3) and JP21 (5-
GCCGGTACCG TACATTGGTT GGCCGGGTTT TAACTG-3).
JP20 annealed to the 5 end of the MF1 open reading frame after
the codon for Ala 19. This eliminated the signal sequence or “pre”
region of the MF1 gene product. JP21 annealed directly 5 to the
stop codon of MF1. Both of these primers included a KpnI site for
cloning the amplified product into KS-ERV14-2NXT-HA. The result-
ing plasmid encoded full-length Erv14p with pro-factor fused to
the carboxy terminus followed by the HA epitope and was referred
to as KS-ERV14-pro-factor-HA.
Single Residue Change Mutants. Single codon mutations (Y80A and
D93A) were made by site-directed mutagenesis. Oligonucleotide
JP28 was used as the selection primer in conjunction with JP31
(5-GTAGATCTTG TTTAGATTGG CAGCTAGAAC TGGTA-
AGTT-3), which was used to create a site-directed mutation con-
verting a tyrosine residue to an alanine at position 80 of ERV14 in
the plasmid pRS316-ERV14-HA, resulting in the plasmid KS-
ERV14-(Y80A)-HA. Similarly, KS-ERV14-(D93A)-HA was con-
structed using oligonucleotides JP28 and JP33 (5-TCTGAATAT
TTCGGTAGCA GCCAAAAGTT GAACTTTATTG-3) to convert
the codon for aspartic acid 93 to an alanine.
Construction of Alanine Stretch Mutants. The codons for amino
acid residues 91 through 95 were mutated to encode alanines in
pRS316-ERV14-HA by site-directed mutagenesis. Oligonucleotides
JP28 and JP36 (5-GCCTAAAGTT CTGAATATTT CGGCAGCTGC
AGCAGCTTGA ACTTTATTGT AGATCTTG-3) were used for se-
lection mutation and for site-directed mutation, respectively. Simi-
larly, the codons for amino acids 97–101 were converted to alanines
by using JP28 with JP37 (5-GGAAACTCTC CCTTTTATGT TTGC-
CTGCAG CTGCGGCTGC TTCGGTAGCA TCCAAAAGTT GAAC-
3). These plasmids were referred to as KS-ERV14(91-95A)-HA and
KS-ERV14(97-101A)-HA. In all instances, constructs were subjected
to DNA sequence analysis to confirm correct synthesis.
Strain Construction
Oligonucleotides JP34 (5-GGTCAAGTTA AGGACATTCA CG-
GACGCATC CCAGAAATGC TGCGGATCCC CGGGTTAATT
AA-3) and JP35 (5-ACAGGAAAAT AAAATTAAGC AAAAT-
ATCGT TGCGTATAAG AATTCGAGCT CGTTTAAAC-3) were
used with plasmid template pFA6a-13Myc-TRP1 in a one-step PCR-
mediated technique to C-terminally tag the chromosomal allele of
AXL2 with 13 sequential c-myc epitopes (Longtine et al., 1998). One
of the positive isolates (CBY800) was characterized and used for
further studies. A similar procedure was used to introduce myc-
tagged Axl2p in strain CBY355 to generate strain CBY807, except the
template pFA6a-13Myc-His3MX6 was used.
COPII-dependent Transport and Binding Assays
Reconstituted assays to measure the budding and transport effi-
ciency of [35S]glyco-pro-factor (gpF) have been previously de-
scribed (Barlowe, 1997). The data plotted in these experiments are
the average of duplicate determinations and the error bars represent
the range. To measure the efficiency of protein packaging into COPII
vesicles, reconstituted vesicle synthesis reactions were performed
from isolated microsomes as described (Barlowe et al., 1994). In
Sar1-GST binding assays, ternary complexes were formed and iso-
lated from microsomes after incubation with Sar1p-GST and Sec23/
24p complex as described (Kuehn et al., 1998).
Factor Xa Cleavage of Erv14p-fXa Fusion Proteins
Factor Xa digests were performed on isolated microsomal mem-
branes containing Erv14p-fXa-(V44)-HA or Erv14p-fXa-(L92)-HA
(Nagai and Thørgersen, 1984). Microsomes (3 g of total membrane
protein) in 10 l of factor Xa buffer (100 mM NaCl, 50 mM Tris-HCl
pH 8.0, 1 mM CaCl2, 2 mM EDTA, 250 mM sorbitol) were incubated
with or without 0.2% NP-40 for 15 min on ice. Samples were then
treated with or without 1 g of factor Xa (Promega, Madison, WI)
and incubated at 4°C for 18 h. Reactions were terminated by the
addition of 10 l of tricine sample buffer and heated at 95°C for 3
min. Samples were resolved on 16.5% Tris/tricine gels, transferred
to nitrocellulose, and immunoblots were probed with the anti-HA
antibody. For proteinase K digests, 10 g of total membrane protein
was treated with 3 g of proteinase K in 25 l of factor Xa buffer
plus or minus 0.2% NP-40 for indicated times at 4°C.
Endoglycosidase H (Endo H) Digestion of
Glycosylated Erv14p-pro-factor-HA
Microsomal membranes (200 g of total membrane protein) were
solubilized in 1% SDS, heated for 2 min at 95°C, and diluted with 1
ml of concavalin A (Con A) buffer (20 mM Tris-Cl pH 7.5, 0.5 M
NaCl, 1% Triton X-100). After a centrifugation at 14 K for 5 min, 1 ml
was removed to a new tube and incubated with 30 l of 20% Con
A-Sepharose for 2 h at room temperature. The beads were washed
three times with 1 ml of Con A buffer then with 1 ml of IP buffer (20
mM Tris-Cl pH 7.5, 0.5 M NaCl, 1% Triton X-100). After the final
wash, the contents of the tube were aspirated to 20 l and bound
proteins were released from beads by the addition of an equal
volume of 2% SDS/1% -mercaptoethanol and heated at 95°C for 3
min. The pH was reduced by addition of 20 l of 100 mM sodium
citrate, pH 5.5. Samples were then incubated overnight at 37°C with
or without 5 mU of endoglycosidase H (Sigma Chemical, St. Louis,
MO). Reactions were terminated with 15 l of 5 SDS-PAGE sam-
ple buffer and heated for 3 min at 95°C. Total and Con A-precipi-
tated samples were analyzed by immunoblot for Erv14p-pro-fac-
tor-HA and Sec12p.
Immunoprecipitation Experiments
For immunoprecipitation of Erv14p-HA, 50 l of microsomes (160
g of total membrane protein) was solubilized in an equal volume
of 0.5% digitonin/buffer88-8 at 25°C for 10 min (Kuehn et al., 1998).
After centrifugation at 14,000 rpm for 10 min at 4°C to remove
unsolubilized material, the supernatant fluid (100 l) was trans-
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ferred to a fresh tube. Solubilized material was diluted with 3
volumes of 0.5% digitonin/buffer88-8 and HA-tagged proteins im-
munoprecipitated by addition of 0.6 g of anti-HA monoclonal
antibody and 25 l of 20% protein A-Sepharose beads. In extract
mixing experiments, equal amounts of solubilized extracts were
mixed before dilution. After binding for 60 min at 4°C, beads with
bound protein were washed a total of three times with 0.5% digi-
tonin/buffer88-8. Finally, the bound protein was released from
beads by addition of 25 l of SDS-PAGE sample buffer and heated
at 95°C for 3 min. Complexes from one-half of the immunoprecipi-
tates were resolved on polyacrylamide gels and immunoblotted for
Sec61p, Kar2p Erv14p-HA, or Axl2p-myc.
RESULTS
Erv14p Is Required for Incorporation of Axl2p into
COPII-coated Vesicles
Our previous studies showed that erv14 strains accumu-
lated Axl2p in the ER by an unknown mechanism. To de-
termine whether Erv14p acts in packaging of Axl2p into
ER-derived transport vesicles, we first monitored the incor-
poration of specific proteins into COPII vesicles by using an
in vitro budding assay that reconstitutes vesicle formation
from washed ER membranes (Salama et al., 1993). For these
experiments, the detection of Axl2p was facilitated by mod-
ifying the chromosomal copy of AXL2 to express 13 tandem
c-myc epitopes (Longtine et al., 1998). The tagged version of
Axl2p was functional as assessed in bud site selection assays
(Table 2) and the ER form of Axl2p-myc migrates as a
180-kDa glycoprotein. Wild-type membranes budded
Axl2p-myc more efficiently (4.2%) than erv14 membranes
(0.7%) (Figure 1A). Sec61p, an integral membrane protein
that acts in protein translocation and resides in the ER
(Stirling et al., 1992), served as a negative control and was
not efficiently packaged into vesicles from either strain.
Bos1p and Erv25p are vesicle proteins that cycle between the
ER and Golgi compartments (Newman et al., 1992; Belden
and Barlowe, 1996) and were packaged into ER-derived
vesicles from both membranes. However, we observed that
the overall budding efficiency in erv14 membranes was
lower than in wild-type membranes. In wild-type reactions,
Bos1p budding efficiency was 15% compared with 8.3% in
erv14 reactions and Erv25p budding efficiency was 14% in
wild-type compared with 8.4% in erv14 reactions. This
effect was not related to the presence of epitope tags on
Axl2p or Erv14p because the same decrease was observed
when untagged strains were used (Figure 1B) and when
budding (Figure 1C) and transport (Figure 1D) of the soluble
secretory protein gpf was monitored (Barlowe, 1997). Thus,
erv14 also appears to have a general effect on the efficiency
of COPII vesicle formation in vitro and we investigate this
further in later sections of the report. To summarize, erv14
caused a strong block in Axl2p packaging (6-fold reduction),
whereas other cargo monitored (Bos1p, Erv25p, and gpf)
were reduced 1.3–1.8-fold. These results demonstrated that
ER membranes lacking Erv14p bud COPII vesicles but that
Axl2p was not efficiently incorporated.
Erv14p Binds to Subunits of COPII Coat
The COPII coat consists of the small GTPase Sar1p and two
larger heteromeric proteins, Sec23/24p complex and Sec13/
31p complex. The activated form of Sar1p is thought to bind
cargo proteins on the membrane surface of the ER, and then
attract Sec23/24p, followed by Sec13/31p (Springer et al.,
1999). Previous studies have demonstrated that components
of the COPII coat form prebudding complexes with vesicle
cargo proteins. More specifically, ternary complexes be-
tween GST-Sar1p, Sec23/24p and vesicle cargo can be
formed in vitro and then isolated from detergent-solubilized
membranes by binding to glutathione agarose. Stable ter-
nary complex formation depends on locking the Sar1p
GTPase into an activated conformation by inclusion of a
nonhydrolyzable form of GTP, such as guanylyl-imidophos-
phate GMP-PNP (Aridor et al., 1998; Kuehn et al., 1998).
Using this approach, we tested the hypothesis that Erv14p
forms a specific prebudding complex with COPII subunits.
We performed in vitro COPII binding assays (Kuehn et al.,
1998), incubating microsomes prepared from an epitope-
tagged form of Erv14p with various combinations of GST-
Sar1p, Sec23/24p, and GMP-PNP. After solubilization of
membranes with digitonin, GST-Sar1p complexes were iso-
lated by binding to glutathione agarose. As seen in Figure 2,
Erv14p bound to GST-Sar1p in a reaction that depended on
the presence of Sec23/24p and GMP-PNP. Omission of ei-
ther one of these components resulted in at least 10-fold less
binding (our unpublished data). As negative controls for this
experiment, Kar2p (a soluble ER resident chaperone) and
Table 2. Complementation of nonaxial budding phenotype with ERV14 constructs
Of log phase cells bearing at least six bud scars, those that had at least one scar on an opposite pole were classified as exhibiting a nonaxial
phenotype.
Strain
No. of cells exhibiting nonaxial
budding/300 cells % Nonaxial budding
CBY807 (WT) 0 0.0
CBY800 (erv14) 37 12.3
CBY812 (erv14/pRS316) 29 9.7
CBY813 (erv14/pRS316-ERV14-HA) 0 0.0
CBY867 (erv14/KS-ERV14-(Y80A)-HA) 0 0.0
CBY868 (erv14/KS-ERV14-(D93A)-HA) 0 0.0
CBY816 (erv14/ KS-ERV14-(91-95A)-HA) 8 2.7
CBY817 (erv14/ KS-ERV14-(97-101A)-HA) 52 17.3
CBY866 (erv14/ pRS315-ERV14) 0 0.0
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Sec61p, which are not efficiently packaged into COPII vesi-
cles, were not detected in complex with GST-Sar1p. Erv25p,
a transmembrane protein that is efficiently packaged into
COPII vesicles, served as a positive control and was found to
associate with COPII subunits as has been reported for other
p24 proteins (Kuehn et al., 1998). Under these conditions,
2% of the total Erv14p-HA was recovered in complex with
GST-Sar1p. These results demonstrate that Erv14p forms a
specific complex with activated Sar1p and Sec23/24p
through direct or indirect interactions. To gain further in-
sight into the molecular nature of this complex, we next
investigated the membrane topology of Erv14p.
Membrane Topology of Erv14p
Erv14p is an integral membrane protein that possesses three
segments of adequate length and hydrophobicity to span the
membrane. The N terminus of Erv14p does not contain a
predicted signal sequence (Powers and Barlowe, 1998).
These features are shared among all reported Erv14p ho-
mologs. One predictor of membrane topology is the “posi-
tive-inside rule,” which is based on the empirical observa-
tion that positive charges are statistically enriched in the
cytosolic domains of polytopic membrane proteins (von
Heijne and Gavel, 1988). The topology of Erv14p predicted
by this rule places the N terminus in the cytoplasm followed
by three transmembrane segments and a lumenal orienta-
tion for the C terminus (Figure 7). To test this model, we first
determined the accessibility of the HA-epitope when fused
to the C terminus of Erv14p, to generate Erv14p-HA (Powers
and Barlowe, 1998). Controlled immunofluorescence studies
indicated that this epitope was accessible to antibody only in
the presence of detergent (our unpublished data) and sup-
ported a lumenal location for the C terminus. However, to
unambiguously determine the membrane topology for
Erv14p, we performed a series of experiments by first char-
acterizing versions of Erv14p-HA with factor Xa protease
sites inserted into the predicted loop regions and then by
fusing pro-factor to the C terminus.
Figure 1. Erv14p is required for packaging of Axl2p into COPII
vesicles. (A) Immunoblot analysis of reconstituted budding reac-
tions with membranes prepared from wild-type (CBY813; ERV14-
HA, AXL2-myc) and erv14 (CBY800; erv14, AXL2-myc) strains.
One-tenth of the total budding reaction (Total) is compared with
isolated budded vesicles formed after incubations in the absence ()
or presence of COPII proteins (). (B) COPII budding reactions as in
A except untagged wild-type (CBY355) and erv14 (CBY356) strains
were used and Erv14p detected with anti-Erv14p serum. (C) COPII-
dependent budding of [35S]gpF from semi-intact cell membranes
prepared from CBY355 (WT) and CBY356 (erv14) strains. Mem-
branes were incubated alone (open bars) or with purified COPII
proteins (solid bars). (D) Reconstituted transport between the ER
and Golgi complex. Amount of outer-chain modified [35S]gpF in
semi-intact cell membranes incubated alone (open bars) or in the
presence of COPII, Uso1p, and LMA1 (solid bars).
Figure 2. Erv14p forms a complex with COPII subunits. Micro-
somes prepared from strain CBY409 (expressing Erv14p-HA) were
incubated with GMP-PNP, Sec23/24p complex, and Sar-GST as
indicated. Proteins recovered on glutathione Agarose (GSHA
Bound) were detected by immunoblot. The total lane (Total) repre-
sents 2% of binding reactions.
J. Powers and C. Barlowe
Molecular Biology of the Cell884
The insertion of protease sites into proteins has been used
to determine the topology of polytopic membrane proteins
(Preston et al., 1994; Wilkinson et al., 1996). Factor Xa is a
highly specific serine protease that catalyzes the activation
of prothrombin to thrombin and cleaves on the C-terminal
side of a tetrapeptide repeat, IEGR (Magnusson et al., 1975).
Therefore, factor Xa sites were inserted independently into
each of the putative loop domains of Erv14p-HA. If inserted
sites are accessible to protease in the absence of detergent, a
cytosolic location is suggested, whereas protease protection
is indicative of a lumenal orientation. Factor Xa protease
sites were introduced into the more N-terminal hydrophilic
loop at position V44 (Erv14p-V44-HA) or the more C-termi-
nal hydrophilic loop at position L92 (Erv14p-L92-HA) (Fig-
ure 7). Expression of these modified versions of Erv14p-HA
from CEN-based vectors in an erv14 strain resulted in
wild-type expression levels and proper localization to the
ER (our unpublished data).
To determine the protease accessibility of these factor Xa
sites, microsomes were prepared and subjected to protease
digestion in the presence and absence of detergent (Figure
3A). The resulting products were analyzed by immunoblot
by using the anti-HA antibody that recognizes the C-termi-
nal epitope on these constructs. The full-length protein of
both constructs was predicted to be 17 kDa. The appear-
ance of the 12-kDa cleavage product detected by anti-HA
antibody from microsomes with the Erv14p-V44-HA con-
struct depended on membrane solubilization with deter-
gent. In contrast, the 6.5-kDa immunoreactive cleavage
product from the Erv14p-L92-HA construct was detected in
the presence or absence of detergent. The integrity of these
microsomal membrane preparations was demonstrated by
the protection of Kar2p, an ER lumenal protein, from pro-
teinase K digestion in the absence of detergent (Figure 3B).
These results indicated that the N-terminal hydrophilic loop
was located in the ER lumen and was protease protected,
whereas the C-terminal loop was cytoplasmically exposed.
We chose an independent method to confirm this topol-
ogy that does not rely on protease sensitivity. We reasoned
that if the C terminus of Erv14p faces the ER lumen, a
C-terminal fusion with a protein containing consensus se-
quences for asparagine-linked (N-linked) glycosylation
should result in the expression of a glycoprotein. The -fac-
tor pheromone precursor prepro--factor contains a cleav-
able signal sequence and acquires three N-linked core-gly-
cosylation residues in the ER lumen. This protein is further
modified and proteolytically processed as it traverses the
yeast secretory pathway and ultimately secreted as mature
-factor (Fuller et al., 1988). We fused the pro-factor region
(lacking the signal sequence) to the C terminus of Erv14p,
directly before the HA tag to generate Erv14-pro-factor-HA
(Erv14-pF-HA). As seen in Figure 3C, expression of this
chimera from a CEN plasmid (strain CBY732) resulted in the
production of two immunoreactive species corresponding to
sizes expected for a fully glycosylated fusion protein (38
kDa) and an unglycoslyated form (32 kDa). The fusion
protein was expressed at an apparently lower level than
observed for Erv14p-HA (strain CBY409), perhaps due to
heterogeneity in outer-chain modification or proprotein pro-
cessing and loss of the HA epitope in the Golgi complex. To
confirm that the immunoreactive species migrating at 38
kDa was a glycoprotein, microsomes from this strain were
solubilized and total glycosylated proteins were precipitated
with Con A bound to Sepharose beads. This method con-
centrated the 38-kDa HA-tagged species, Erv14-pF-HA,
whereas Erv14p-HA was not precipitated (Figure 3C, lanes 3
and 4). As a positive control for this procedure, the ER
glycoprotein Sec12p (Nakano et al., 1988) bound Con A to an
equal extent from both of these solubilized membrane prep-
arations. Finally, treatment of the Con A-precipitated pro-
teins with Endo H, to cleave core-linked oligosaccharides,
reduced the size of Erv14p-F-HA (Figure 3C, lane 6). As
expected, this treatment resulted in an 6-kDa shift, which
Figure 3. Membrane topology of Erv14p. (A) Factor Xa cleavage of
Erv14p-(V44)-HA and Erv14p-(L92)-HA proteins in microsomes
prepared from CBY707 and CBY731, respectively. Where indicated,
membranes were solubilized with 2% NP-40. Proteolytic fragments
were resolved on 16% Tris/tricine gels and immunoblotted with
anti-HA. (B) Proteinase K protection of Kar2p to demonstrate integ-
rity of V44 and L92 containing microsomal membranes. (C) Micro-
somes prepared from CBY409 expressing Erv14p-HA (lanes 1, 3, 5)
and CBY732 expressing the Erv14p-pro-Factor-HA fusion protein
(lanes 2, 4, and 6) were solubilized with detergent. Total solubilized
proteins (lanes 1 and 2) were compared with Con A-bound glyco-
proteins (lanes 3 and 4) and glycoproteins treated with endoglyco-
sidase H (lanes 5 and 6).
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probably corresponds to the removal of three N-linked oli-
gosaccharides (Orlean et al., 1991). Sec12p, which contains
two core-linked oligosaccharides (Nakano et al., 1988),
served as a control for this method and displayed Endo H
sensitivity in our assay, shifting from 70 to 65 kDa in both
strains. These collective results provide convincing evidence
that the C terminus of Erv14p is located in the lumen and
support the topology predicted by the positive inside rule.
Molecular Dissection of Erv14p
Based on the membrane topology of Erv14p, we focused our
attention on the cytoplasmic loop region spanning amino
acid residues 79–110 and hypothesized that this region may
interact with the COPII budding machinery. To test this
idea, we mutated conserved amino acid residues in this
region to alanines. In aligning the sequence of Erv14p with
homologs across several species (S. cerevisiae, C. elegans, D.
melanogaster, D. virilis and M. musculus) remarkable regions
of identity were observed (Figure 7) with invariant amino
acid residues found at tyrosine 80, leucine 91, aspartate 93,
and leucine 101. Using site-directed mutagenesis, we made
modest changes, independently converting tyrosine 80 or
aspartate 93 to alanines, and more drastic changes mutating
residues 91–95 or 97–101 to alanines. We then expressed
these constructs from CEN-based plasmids in an erv14
strain and determined their expression levels and assessed
their ability to complement the defect in bud site selection
(Table 2). All of these mutant forms of Erv14p-HA were
expressed to similar levels as the wild-type protein when
analyzed by anti-HA immunoblot (Figure 4A). In bud site
selection assays, the alanine stretch mutant Erv14p(91-
95A)-HA displayed a modest defect in axial bud site selec-
tion and the mutant Erv14p(97-101A)-HA displayed a defect
as severe as the erv14 strain (Table 2). No defects were
detected in the Y80A or D93A mutants by this assay. In
strains where nonaxial budding patterns were observed, the
ER form of Axl2p accumulated (our unpublished data).
We next tested the influence of the Erv14p(91-95A)-HA
and Erv14p(97-101A)-HA mutations on COPII-dependent
vesicle formation from the ER. In the first set of experiments,
the efficiency of [35S]gpF budding efficiencies in the ab-
sence and presence of COPII was determined as follows:
7.7  0.7 and 37  0.5% from Erv14p-HA membranes; 9.8 
0.7 and 29  0.2% from erv14 membranes; 10.2  0.5 and
40.3  1.5% from Erv14p(91-95A)-HA membranes; and
8.1  0.2 and 25  0.3% from Erv14p(97-101A)-HA mem-
branes. These results indicated that loss of function muta-
tions in ERV14 reduced the budding efficiency of [35S]gpF
as we had observed in Figure 1. To monitor the packaging
efficiency of other vesicle cargo proteins, COPII vesicles
were generated from these membranes and specific cargo
detected by immunoblot (Figure 4B). In general, these re-
sults mirrored what was observed for [35S]gpF budding.
Erv14p-HA was packaged at 13%, whereas Erv14p(91-
95A)-HA and Erv14p(97-101A)-HA were packaged at 11 and
4%, respectively. The vesicle protein Bos1p was incorpo-
rated into vesicles at an efficiency of 14% from wild-type
membranes, 8% from Erv14p(91-95A)-HA membranes, and
4% from Erv14p(97-101A)-HA membranes. Therefore, the
more severe alanine stretch mutant, Erv14p(97-101A)-HA,
appeared to be a stable loss of function protein that was not
efficiently packaged into COPII vesicles.
Mutations in Cytoplasmic Loop of Erv14p Influence
COPII Binding
Alanine mutations in the cytoplasmic loop of Erv14p caused
defects in axial bud site selection in vivo and decreased its
packaging efficiency into COPII vesicles in vitro. Together,
these results suggested that mutation of residues 97–101 in
Erv14p to alanines interfered with an association between
Erv14p and the COPII coat. To test this possibility, we per-
formed GST-Sar1p binding assays to determine whether
Erv14p(91-95A)-HA and Erv14p(97-101A)-HA formed ter-
nary complexes as efficiently as wild-type Erv14p-HA. As in
previous experiments, wild-type Erv14p-HA specifically
bound to glutathione agarose under conditions where GST-
Sar1p, Sec23/24p, and GMP-PNP were present (Figure 4C).
In contrast, Erv14p(91-95A) displayed a slight decrease in
binding level and Erv14p(97-101A)-HA failed to bind in this
assay. Similar levels of Erv25p from all three membrane
preparations were captured in GST-Sar1p complexes, indi-
cating these membranes were competent for COPII binding.
Other ER-resident proteins were excluded from GST-Sar1p
complexes, indicating specificity of the COPII–cargo inter-
Figure 4. Residues in the cytoplasmic loop of Erv14p are required
for COPII binding. (A) Expression levels of Erv14p-HA in CBY355
(wild-type), CBY800 (erv14), CBY813 (Erv14p-HA), CBY867
(Y80A), CBY868 (D93A), CBY816 (91-95A), and CBY817 (97-101A)
strains determined by immunoblot. (B) COPII vesicle budding from
CBY409 (wild-type) CBY356 (erv14), CBY808 (91-95A) and CBY809
(97-101A) microsomes as in Figure 1. (C) Isolation of COPII com-
plexes from CBY409 (wild-type), CBY808 (91-95A), and CBY809
(97-101) microsomes as in Figure 2 except lanes 2, 6, and 10 are
beads alone; lanes 3, 7, and 11 are complete reactions minus GMP-
PNP; and lanes 4, 8, and 12 are complete reactions (GMP-PNP,
Sec23p/24p complex, and Sar1-GST).
J. Powers and C. Barlowe
Molecular Biology of the Cell886
actions. Based on these observations, we propose that resi-
dues 97–101 in Erv14p are critical for COPII binding and
recruitment of this protein into vesicles.
Erv14p Associates with Axl2p in ER Membranes
Previous whole cell immunofluorescence experiments and
sucrose gradient fractionation of membrane organelles doc-
umented an ER/Golgi localization pattern for Erv14p and
suggested that this protein cycles between these compart-
ments (Powers and Barlowe, 1998). To determine the sub-
cellular distribution of Erv14p(97-101A)-HA compared with
wild-type Erv14p-HA, cell membranes were prepared and
organelles resolved as previously described (Antebi and
Fink, 1992; Powers and Barlowe, 1998). As seen in Figure 5B,
conversion of amino acid residues 97–101 to alanines shifted
Erv14p localization to the ER. In these gradients, Kar2p
served as an ER marker that peaked in fractions 10 and 11
and Emp47p, a Golgi membrane marker, peaked in fractions
5 and 6. In wild-type cells, approximately equal amounts of
Erv14p were detected in the ER and Golgi fractions, whereas
75% of Erv14p(97-101A)-HA localized to the ER fractions.
These results indicate that the reduced budding efficiency of
Erv14p(97-101A)-HA from ER membranes causes an accu-
mulation of Erv14p(97-101A)-HA in this compartment.
Our results are consistent with the idea that Erv14p con-
nects Axl2p to the COPII coat during export from the ER.
However, we have been unable to detect an association
between wild-type Erv14p and the secretory cargo Axl2p.
We reasoned that the Erv14p(97-101A)-HA mutant may ac-
cumulate an Erv14p/Axl2p complex in the ER, allowing for
detection of this putative intermediate. To test this possibil-
ity, we constructed strains expressing Erv14p(97-101A)-HA
and Axl2p-myc for immunoprecipitation experiments. Mi-
crosomal membranes from strains expressing Erv14-HA or
Erv14p(97-101A)-HA and Axl2p-myc were solubilized with
digitonin. HA-tagged proteins were immunoprecipitated
and the amount of Axl2p-myc associated with these native
immune complexes determined by immunoblot (Figure 5C).
Strikingly, an Erv14p-Axl2p complex was detected only in
membranes expressing Erv14p(97-101A)-HA and Axl2p-
myc. In membranes lacking Erv14p or expressing wild-type
Erv14p-HA, Axl2p-myc was not detected even though the
erv14 strain accumulates maximum levels of Axl2p-myc in
the ER. Together with the observation that other abundant
ER proteins (e.g., Kar2p and Sec61p) were not detected in
any of these immunoprecipitations, the data indicate that
this association was specific. Approximately 10% of the total
Erv14p(97-101A)-HA and 0.7% of the total Axl2p-myc were
recovered in these anti-HA immunoprecipitations. To fur-
ther investigate the specificity of this association, we found
that the Erv14p-Axl2p complex is present in membranes and
does not occur after detergent solubilization (Figure 5D). In
this experiment, solubilized membranes from strains ex-
pressing either Erv14p(97-101A)-HA or Axl2p-myc were
mixed before immunoprecipitation. An Erv14p-Axl2p asso-
ciation was not detected in mixed extracts but was observed
when the proteins originate in the same membrane (Figure
5D). These results suggest that this Erv14p-Axl2p complex
represents an intermediate in export of Axl2p from the ER
and that Erv14p performs a direct role in loading Axl2p into
COPII vesicles.
Figure 5. Erv14p(97-101A)-HA accumulates in the ER and is de-
tected in complex with Axl2p. Subcellular distribution of
Erv14p-HA (A) compared with Erv14p(97-101A)-HA (B). Emp47p
serves as a Golgi-localized marker and Kar2p serves as an ER-
localized marker. (C) Immunoblots of native anti-HA immunopre-
cipitations from CBY800 (erv14), CBY813 (Erv14HA), and CBY817
(97-101A)-solubilized microsomes. Total lanes (Total) represent 5%
of immunoprecipitation (IP) lanes. Note specific coimmunoprecipi-
tation of Axl2-myc with Erv14p(97-101A)-HA. (D) Solubilized mi-
crosomes were prepared from CBY809 [Erv14p(97-101A)-HA],
CBY812 (Axl2-myc), and CBY817 [Erv14p(97-101A)-HA/Axl2-myc].
Native anti-HA immunoprecipitations from CBY812 (812), mixed
extracts from CBY809 plus CBY812 (Mix), and CBY817 (817). Note
specific coimmunoprecipitation of Axl2-myc from the CBY817 ex-
tract but not from mixed extracts of CBY809 plus CBY812.
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Genetic Analysis of ERV14
In vitro budding experiments shown in Figure 1 and else-
where indicated that Erv14p was required for packaging of
Axl2p into ER-derived vesicles but was also required for
optimal budding of COPII vesicles. This appears to be a
general effect on COPII vesicle formation because Bos1p,
Erv25p, and [35S]gpF budding efficiencies were reduced in
vitro when Erv14p was absent. However, deletion of ERV14
has a modest impact on growth and overall secretion rates in
vivo (Powers and Barlowe, 1998; Otte et al., 2001). To pro-
vide further insight on a general role of ERV14 in budding,
we tested whether deletion of ERV14 influenced the pheno-
types associated with temperature-sensitive sec mutants in-
volved in budding and transport between the ER and Golgi
complex. Examples of suppression and exacerbation of tem-
perature sensitivity have been previously reported for other
nonessential genes that operate in protein export from the
ER (Elrod-Erickson and Kaiser, 1996; Gilstring et al., 1999).
To test this possibility, an erv14 strain was mated with
strains that carried thermosensitive alleles involved in CO-
PII vesicle formation (sec12, sec13, sec16, sec23), vesicle fusion
(sec18), or COPI vesicle formation (sec21). After sporulation
of these diploids and dissection at room temperature, four
viable spores were recovered from each tetrad. Haploids
were scored for growth at room temperature (23°C), 28, 34,
and 37°C to determine the impact of erv14 on thermosen-
sitivity. Although no phenotype, as defined by synthetic
growth effect, was observed when ERV14 was deleted in a
sec12-4 background, an increased thermosensitivity was ob-
served for double mutant segregants containing the sec13-1,
sec16-2, or sec23-1 alleles (Table 3). A slow growth phenotype
was observed for the erv14 sec13-1 strain at 23°C and this
strain was inviable at 28°C. When the sec23-1 allele was
present in an erv14 background, there was again no growth
at 28°C (Figure 6), although colony size was similar to that of
the wild-type strain at room temperature (our unpublished
data). Similar results were obtained for the sec16-2 allele. In
contrast, an erv14mutation had no impact on the growth or
thermosensitivity of strains containing either the sec18-1 or
sec21-1 allele (Table 3). The lack of a synthetic phenotype in
strains carrying either sec18-1 or sec21-1 in an erv14 back-
ground may indicate that these genes do not act in the same
stage of transport as Erv14p. That is, Erv14p would not be
predicted to function at either vesicle fusion or in retrograde
vesicle trafficking between the Golgi and ER. However, the
exacerbation of temperature sensitivity by erv14 when
combined with genes involved in COPII vesicle formation
suggests that Erv14p participates in this stage of the path-
way.
These genetic experiments corroborate our in vitro bud-
ding results and suggest that Erv14p performs a role in
COPII vesicle formation. It was possible that erv14 some-
how impaired our recovery of budding competent micro-
somes used for in vitro assays. However, the specific genetic
relationships between erv14 and genes encoding COPII
subunits indicate that the in vitro assay reflects an authentic
role for Erv14p in vesicle formation. In other instances, we
have found the in vitro assays provide a more sensitive
method than in vivo approaches to monitor defects in trans-
port between the ER and Golgi (Conchon et al., 1999; Otte et
al., 2001). Based on these results, we conclude that Erv14p
acts in cargo selection and also facilitates COPII vesicle
formation.
DISCUSSION
Erv14p was previously shown to be selectively packaged
into COPII vesicles and required for in vivo export of an
integral membrane secretory protein, Axl2p, from the ER. In
this study, we demonstrate that Erv14p genetically and
physically interacts with subunits of the COPII coat. To
identify regions of the Erv14p protein responsible for this
interaction, we determined the membrane topology of
Table 3. Influence of erv14 on sec mutations
Relative growth rates for erv14 and sec/erv14 haploids com-
pared with a wild-type haploid.
Thermosensitive allele 23°C 28°C 34°C
sec12-4   
sec12-4 erv14   
sec13-1   
sec13-1 erv14   
sec16-2   
sec16-2 erv14   
sec23-1   
sec23-1 erv14   
sec18-1   
sec18-1 erv14   
sec21-1   
sec21-1 erv14   
, signifies similar growth to wild-type,  and  signify
varying degrees of poor growth, and  signifies no growth.
Figure 6. Disruption of ERV14 exacerbates the thermosensitivity
of a sec23-1 strain. An erv14 strain was crossed with a sec23-1 strain
and the resulting haploid spores were tested for growth at 28°C.
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Erv14p and found that the protein spans the bilayer three
times and possesses a cytoplasmically oriented 30 amino
acid loop region. Residues 97–101 within this conserved
loop region of Erv14p were found to be critical for function,
for recruitment into COPII vesicles and for association with
subunits of the COPII coat. Finally, a mutant form of Erv14p
that failed to engage the COPII budding machinery accu-
mulated in the ER and was detected in association with the
secretory cargo Axl2p. Based on these observations, we pro-
pose that Erv14p serves as an adaptor that links an integral
membrane secretory protein to the COPII vesicle coat.
The mechanisms underlying selective transport of pro-
teins between the ER and Golgi remain unclear. Evidence
indicates that certain integral membrane cargoes are re-
cruited and concentrated into COPII vesicles during export
from the ER (Klumperman, 2000). For example, Bet1p binds
directly to subunits of the COPII coat (Springer and Schek-
man, 1998) and is concentrated into COPII-coated vesicles
(Martinez-Menarguez et al., 1999). Other transmembrane se-
cretory proteins, such as histidine permease, vesicular sto-
matitis virus glycoprotein, and plasma membrane ATPase
have been shown to bind specific subunits of the COPII coat
(Aridor et al., 1998; Kuehn et al., 1998; Shimoni et al., 2000). In
the case of the histidine permease, an ER resident protein,
termed Shr3p, appears to coordinate the association of per-
mease with coat (Kuehn et al., 1996; Gilstring et al., 1999). For
lumenal secretory proteins, evidence for concentration dur-
ing export from the ER has also been reported (Mizuno and
Singer, 1993; Kuehn et al., 1998). In one well characterized
example, the Emp24 complex was shown to bind a GPI
anchored secretory protein in the ER and was required for
packaging of this cargo into ER-derived vesicles (Muniz et
al., 2000). However, evidence for bulk flow of lumenal se-
cretory cargo from the ER has also been provided (Wieland
et al., 1987; Martinez-Menarguez et al., 1999). Indeed, both
receptor-mediated and bulk flow export mechanisms may
operate, depending on cell type and expression levels of a
given secretory cargo (Warren and Mellman, 1999).
In comparison with other documented examples of selec-
tive export, Erv14p seems to act through a novel mechanism.
Herein, export of a specific integral membrane secretory
protein, Axl2p, depends on a second integral membrane
protein, Erv14p, that cycles between the ER and Golgi com-
partments. Erv14p function resembles the role that Shr3p
performs in export of amino acid permeases from the ER but
is clearly distinct because Shr3p is not efficiently packaged
into COPII vesicles (Kuehn et al., 1996). It is not clear why
Axl2p alone lacks sufficient information for packaging into
COPII vesicles as appears to be the case for other integral
membrane cargo (Aridor et al., 1998; Springer and Schek-
man, 1998; Shimoni et al., 2000). The cytoplasmic region of
Axl2p is thought to interact with other bud site selection
proteins to orient axial bud sites (Halme et al., 1996; Roemer
et al., 1996). Therefore, this function in bud site selection may
be incompatible with sequences imparting efficient sorting
into COPII vesicles. It remains to be determined whether
association of Erv14p and Axl2p is mediated by transmem-
brane segments or other domains. Both the first lumenal
loop domain and the third transmembrane domain of
Erv14p possess a high percentage of invariant amino acids
(Figure 7) and could participate in intermolecular interac-
tions. The interaction between Erv14p and Axl2p appears to
be transient because our recovery of Erv14p-Axl2p complex
was low. Alternatively, Erv14p may engage several distinct
secretory proteins with Axl2p, representing a small fraction
of the occupied Erv14p molecules. It is also possible that
stable association of Axl2p with Erv14p depends on addi-
tional factors (e.g., COPII subunits) during export from the
ER. Future experiments with purified proteins can test
whether activated Sar1p and Sec23/24p complex stabilizes
associations between Axl2p and Erv14p. Regardless of the
precise arrangement of the Erv14p-Axl2p complex, we pro-
Figure 7. Model depicting Erv14p structure.
The N terminus is cytoplasmically exposed,
whereas the C terminus is in the lumen. Or-
ange indicates invariant residues and yellow
indicates conserved (4 of 5 species) residues
in alignment of sequences from S. cerevisiae,
C. elegans, D. melanogaster, D. virilis, and M.
musculus. Arrows show sites of specific mu-
tations described in the text and amino acids
97–101 are proposed to function in COPII
interactions.
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pose that the association is reversible such that binding is
favored in the ER and disfavored at some point after export
from the ER. Disassembly of the COPII coat or a different
chemical environment in post-ER compartments could pro-
mote dissociation. Finally, Erv14p is probably returned to
the ER through a COPI-dependent pathway. Additional
studies will be required to identify signals for retrograde
transport of Erv14p, although residues 97–101 could also be
involved in this process.
In addition to a specific role in Axl2p export, our experi-
ments revealed a general decrease in COPII vesicle forma-
tion in strains that lack functional Erv14p. This defect was
observed in cell-free assays that reproduce COPII-depen-
dent budding of glycopro--factor, Bos1p, and Erv25p.
Moreover, a general role in budding was supported by
genetic experiments showing that erv14 exacerbated the
growth phenotypes exhibited by temperature-sensitive mu-
tations in genes that function in budding from the ER
(SEC13, SEC16, and SEC23), whereas vesicle fusion (SEC18)
and COPI (SEC21) mutants were not influenced. A molecu-
lar explanation for this defect remains to be determined.
There could be indirect consequences of cargo accumulation
or Erv14p could facilitate budding by recruiting COPII sub-
units to bud sites on the ER membrane. In this second
scenario, COPII prebudding complexes would form on
many different vesicle proteins, including Erv14p, and a
threshold level of prebudding complexes would be required
to produce a COPII vesicle. Accordingly, the total number of
COPII prebudding complexes would be significantly re-
duced in erv14 membranes and the extent of vesicle bud-
ding decreased. In support of this idea, Erv14p appears to be
an abundant integral membrane constituent of COPII vesi-
cles (Otte et al., 2001), is very efficiently packaged into these
transport intermediates, and forms a tight ternary complex
with the coat subunits Sar1p and Sec23p. Other components
of ER/Golgi transport vesicles have been proposed to act
similarly in providing a coat scaffold (Sohn et al., 1996;
Bremser et al., 1999) or to serve as primers for coat formation
(Springer and Schekman, 1998). However, it also seems pos-
sible that different integral membrane cargo are collectively
required for efficient formation of coated vesicles and loss of
a single abundant constituent such as Erv14p could reduce
but does not prevent vesicle budding.
In summary, we have provided molecular insight on
Erv14p function, indicating this protein acts in concert with
the COPII coat in sorting an integral membrane secretory
protein during export from the ER. The cross-species con-
servation of Erv14p is remarkable, suggesting a conserved
mechanism of action. Cornichon, the Erv14p homolog in
Drosophila, has been proposed to fulfill a similar role in the
selective export of a transforming growth factor -like sig-
naling molecule, Gurken, to the oocyte cell surface. Al-
though Gurken and Axl2p are type I transmembrane pro-
teins that traffic to the cell surface, they do not share any
apparent sequence homology. Interestingly, the transmem-
brane residues in Gurken are critical for its transport to the
cell surface, whereas the cytoplasmic domain is dispensable
(Queenan et al., 1999). Therefore, it may be informative to
test a model whereby the transmembrane residues in Axl2p
promote association with Erv14p and incorporation into
COPII-coated vesicles. Finally, our findings suggest that
other integral membrane secretory cargo may rely on adap-
tor-like proteins for efficient export from the ER.
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